HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
2276studies shown
Showing 1,729-1,740 of 2,276
Behavioral study icon
CompletedACTRN12623001026617

Optimising Transition to Residential Aged Care

Official study title

Implementing a Preventative Care Program to optimise mental health during transition into residential aged care

This study has finished and is no longer accepting participants.

In Australia
Anxiety, DepressionInterventional studyAges 18+
Countries
Australia
Sponsor
University of Newcastle
Device study icon
WithdrawnACTRN12622001273774

Effectiveness of dual site Theta Burst Stimulation (TBS) treatment in depression

Official study title

Optimizing the clinical effectiveness of dual site Theta Burst Stimulation (TBS) treatment for individuals with treatment-resistant depression (OPTI-TBS; Study 2)

This study was withdrawn before enrollment.

In Australia
DepressionInterventional studyAges 18–85
Countries
Australia
Sponsor
Australian National University
Drug study icon
TerminatedACTRN12621000429853

Oral Ketamine study on people aged 16 years and older with Treatment-Resistant Depression

Official study title

An open-label clinical trial of oral ketamine, an NMDA (N-methyl-D-aspartate) receptor antagonist on depressive symptomatology in people aged 16 years and older who are experiencing treatment-resistant depression.

This study ended early.

In Australia
DepressionInterventional studyAges 16+
Countries
Australia
Sponsor
Thompson Institute, University of the Sunshine Coast
Drug study icon
CompletedACTRN12618001965291

Oral Ketamine study on PTSD

Official study title

An open-label, dose ranging, clinical trial of oral ketamine, an NMDA (N-methyl-D-aspartate) receptor antagonist, with weekly dosing over six weeks in patients who are experiencing post-traumatic stress disorder (PTSD)

This study has finished and is no longer accepting participants.

In Australia
PTSDInterventional studyAges 18+
Countries
Australia
Sponsor
University of the Sunshine Coast Mind and Neuroscience Thompson Institute
Drug study icon
CompletedACTRN12618001412224

Oral Ketamine study on Suicide prevention

Official study title

An open-label clinical trial of oral ketamine, an NMDA (N-methyl-D-aspartate) receptor antagonist, with weekly dosing over six weeks, in 25-50 patients who are experiencing chronic suicidal ideation.

This study has finished and is no longer accepting participants.

In Australia
SuicidalityInterventional studyAges 18+
Countries
Australia
Sponsor
Sunshine Coast Mind and Neuroscience - Thompson Institute, University of the Sunshine Coast
Behavioral study icon
CompletedACTRN12621000440820

Own Your Balance Study : Effect of a self-managed online cognitive behavioural therapy program in older people with concerns about falling

Official study title

Evaluating the efficacy of a self-managed online cognitive behavioural therapy program with or without an additional graded balance program in community-dwelling older people: a randomised controlled trial.

This study has finished and is no longer accepting participants.

Remote / online
Mental healthInterventional studyAges 65+
Countries
Australia
Sponsor
Neuroscience Research Australia
Other study type icon
CompletedNCT01362426

Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)

Official study title

A Quality Use of Medicine Clinical Registry to Assess Clinical Outcomes in Patients With Schizophrenia Treated With Intramuscular Injections of Paliperidone Palmitate

This study has finished and is no longer accepting participants.

In Australia
SchizophreniaObservational studyAges 18–99
Countries
Australia
Sponsor
Janssen-Cilag Pty Ltd

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.